Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell–Cell Communication in Renal Cell Carcinoma
Autor: | George M. Yousef, Jason Y. Lee, Sergey N. Krylov, Peter M. Szabó, Michael A.S. Jewett, Heba W.Z. Khella, Henriett Butz, Roy Nofech-Mozes, Michael Ordon, Qiang Ding, Robert Stewart, Antonio Finelli |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Pathology medicine.diagnostic_test business.industry Urology Urinary system Cell medicine.disease Exosome Microvesicles 03 medical and health sciences Clear cell renal cell carcinoma 030104 developmental biology 0302 clinical medicine medicine.anatomical_structure Renal cell carcinoma 030220 oncology & carcinogenesis Internal medicine microRNA Biopsy Medicine business |
Zdroj: | European Urology Focus. 2:210-218 |
ISSN: | 2405-4569 |
DOI: | 10.1016/j.euf.2015.11.006 |
Popis: | Apart from an invasive biopsy, currently no tools are available to confirm the diagnosis of clear cell renal cell carcinoma (ccRCC); this resulted in approximately 30% of patients being diagnosed with metastatic disease.To determine whether urinary microRNAs (miRNAs) can serve as biomarkers to confirm the diagnosis of ccRCC.Global miRNA expression was assessed in 28 preoperative urine samples from patients with ccRCC and 18 healthy participants. The independent validation set consisted of 81 ccRCC patients, 24 patients with benign lesions, and 33 healthy participants. We extracted both cell-free and exosomal RNA for miRNA expression analysis using miRNA-specific polymerase chain reaction assays. We also investigated exosomal miRNA secretion in cell line models and performed exosome transfer between RCC and endothelial cell types.Receiver operating characteristic analysis was applied to identify the discrimination power of miRNAs.Overall, miR-126-3p combined with miR-449a or with miR-34b-5p could significantly distinguish ccRCC patients from healthy participants (miR-126-3p-miR-449a: area under the curve [AUC]: 0.84; 95% confidence interval [CI], 0.7620-0.9151; p0.001; miR-126-3p-miR-34b-5p: AUC: 0.79; 95% CI, 0.7013-0.8815; p0.001). The combination of miR-126-3p and miR-34b-5p was also able to distinguish small renal masses (pT1a, ≤4cm) from healthy controls (AUC: 0.79; 95% CI, 0.6848-0.8980; p0.001). Using miR-126-3p and miR-486-5p in combination, we were able to differentiate between benign lesions and ccRCC (AUC: 0.85; 95% CI, 0.7295-0.9615; p0.01). The expression of a number of miRNAs returned to a level comparable with health after surgery. Kidney cancer cell lines were found to secrete exosomal miR-126-3p, miR-17-5p, miR-21-3p, and miR-25-3p, and these miRNAs were found to be internalized by other cell types.We identified exosomal miRNAs as potential noninvasive diagnostic urinary biomarkers for ccRCC and provided evidence that miRNAs are secreted by the tumor and can function as a tool for intercellular communication.We identified urinary microRNAs that can serve as diagnostic biomarkers for clear cell renal cell carcinoma. |
Databáze: | OpenAIRE |
Externí odkaz: |